About Us
Company news
Industry trend
Corporate Culture
Social Responsibility
Contact us
Homepage > News > Industry trend
Industry trend
China Boosts Research in Therapeutic Vaccines
Author:   Source   Date:Jun,08,2014   Browse:6176   
Font:small  medium  big  

Approved by the National Development and Reform Commission, the National Laboratory for Therapeutic Vaccines was launched at Fudan University on June 7. The laboratory will start with Hapatits B vaccines to promote a national level research on therapeutic vaccines.


Apart from preventive vaccines, therapeutic vaccines are new products that are cheap, effective, easy to use and less treatment times. By tuning the body’s immune response, the vaccine will become a new way to fight against chronic infection, tumors and autoimmune disease. After the anti-body drugs, such vaccines have become a hotspot in global biopharmaceutical market.


However in the world by far, only 4 types of tumor related therapeutic vaccines were approved for sale.Mr. Yang Yuliang, who is the principle of Fudan University said that in general the global therapeutic vaccine was still in research and early clinical trials. So it is both China’s strategic demand and the duty of Chinese pharmaceutical researchers to develop self-owned therapeutic vaccines that are affordable, accommodative and competitive in the world.


Experts in the meeting said that although China lags behind with developed countries in therapeutic vaccine variety,it is on par with or even lead in particular areas. Since late 1980s, academician Wen Yumei from Medical School of Fudan University has been focusing on China’s own therapeutic vaccine on Hepatitis B and the product is now in Stage III, period 2 clinic trial.


The lab, co-applied and co-founded by Fudan University and Shanghai Fudan Hai-Tai Biotechnology co., ltd, is headed by academician Wen Yumei. Prof. Lu Shan takes the chair as the executive director and 18 academicians and experts from in and abroad, such as Hou Yunde and Zhao Kai, form the academic advisory committee. Thelab is located at Shanghai Pudong New Area and will be built in 2 years.


It is reported that once established, the lab will, based on modern immunology, promote the technology transfer therapeutic vaccines and provide key generic technology development and public services. The goal is to cultivate innovation mechanism in therapeutic vaccines.

Source: Xinhua

Time: June 7th 2014

Related news
China National Pharmaceutical Group Corporation   INOPHARM FOREIGN TRADE
Contact Us | Site Map | Privacy Policy
Address: Fortune Tower, No.4, Hui Xin Dongjie, Chao Yang District, Beijing 100029, China
E-mail: gly@sinopharmintl.com
Tel: (8610)84618811
Copyright © 2011 sinopharms international
XML 地图 | Sitemap 地图